US Patent Issued to Boehringer Ingelheim International on Aug. 26 for "Imidazopyrazine derivatives and the use thereof as medicament" (German Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,143, issued on Aug. 26, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Imidazopyrazine derivatives and the use thereof as medicament" was invented by Riccardo Giovannini (Biberach an der Riss, Germany) and Dieter Wiedenmayer (Biberach an der Riss, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel imidazopyrazines of general formula A, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with NR2B negative allosteric modulating properties....